ClassID:

94644

C07D261/06 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members

Sub-classes:
Recent Application in this class:
#1
20250250517
2025-08-07

LIQUID COMPOSITION

#2
20240174614
2024-05-30

COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE

#3
20230041335
2023-02-09

COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE

#4
20210269402
2021-09-02

Compositions and methods of treating retinal disease

#5
20190210971
2019-07-11

Compositions and methods of treating retinal disease

#6
20180036294
2018-02-08

9H-pyrimido [4,5-B] indoles as BET bromodomain inhibitors

#7
20170360760
2017-12-21

Inhibitors of bromodomains

#8
20170326149
2017-11-16

Hydroxyl purine compounds and applications thereof

#9
20170304270
2017-10-26

Isoxazole derivatives as FXR agonists and methods of use thereof

#10
20170273947
2017-09-28

N-(5-arylamido-2-methylphenyl)-5-methylisooxazole-4-carboxamide deravative, pharmaceutical acceptable salt thereof, method for preparation therof and FMS kinase inhibitor comprising the same as anactive ingredient

#11
20140193906
2014-07-10

Screening methods for spinal muscular atrophy

#12
20140187592
2014-07-03

Nitrogen-containing aromatic heterocyclyl compound

#13
20130165490
2013-06-27

INSECTICIDAL COMPOUNDS

#14
20120108639
2012-05-03

Nitrogen-containing aromatic heterocyclyl compound

#15
20110263645
2011-10-27

Compositions and methods of treating retinal disease

#16
20100280073
2010-11-04

Tricyclic inhibitors of hydroxysteroid dehydrogenases

#17
20090182009
2009-07-16

Compositions and methods of treating retinal disease

#18
20080269280
2008-10-30

OXO-imidazolidines as modulators of chemokine receptors

#19
20070135481
2007-06-14

Compositions and methods of treating retinal disease